Edesa Biotech appoints Stephen Lemieux as CFO effective July 15, 2023

Edesa Biotech, Inc.

Stephen Lemieux, CPA, appointed CFO; base salary $330K USD plus 40% target annual bonus.
Lemieux brings 20+ yrs experience; previously CFO at Titan Medical and Cipher Pharmaceuticals.
Employment agreement includes severance of 12-24 months salary and change-of-control protections.
CFO will also receive $2K monthly auto allowance and eligibility for equity awards.
Lemieux currently provides financial advisory to Edesa; appointment builds on regulatory progress.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Stephen Lemieux

Chief Financial Officer

EDSA · Edesa Biotech, Inc.

Effective: 2023-07-15
Filed: June 27, 2023, 7:59 PM ET

Edesa Biotech, Inc. (the “Company”) has appointed Stephen Lemieux (age 47) as our Chief Financial Officer pursuant to an employment agreement.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Stephen Lemieux was appointed as Chief Financial Officer at Edesa Biotech, Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

Edesa Biotech, Inc. (the “Company”) has appointed Stephen Lemieux (age 47) as our Chief Financial Officer pursuant to an employment agreement.

View on SEC.gov

Edesa Biotech, Inc. filing history →

Source: SEC EDGAR

accession 0001654954-23-008484

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.